Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.Rafael Rosell,Martyna Filipska,Imane Chaib,David Lligé,Fernando LaguiaFRONTIERS IN ONCOLOGY（2020）引用 2|浏览1暂无评分关键词PD-1,PD-L1,T Cells,CRISPR,PI3K,Akt,MAPK,NSCLCAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
